A Study to Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3)
Bristol-Myers Squibb
Bristol-Myers Squibb
Autolus Limited
SymBio Pharmaceuticals
M.D. Anderson Cancer Center
Fondazione Italiana Linfomi - ETS
City of Hope Medical Center
University of Nebraska
City of Hope Medical Center
Massachusetts General Hospital
Memorial Sloan Kettering Cancer Center
Northwestern University
Celgene
Mayo Clinic
Mayo Clinic
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Acrotech Biopharma Inc.
National Cancer Institute (NCI)
University of Washington
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
National Cancer Institute (NCI)
Samsung Medical Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Asan Medical Center
M.D. Anderson Cancer Center
Northwestern University
UNC Lineberger Comprehensive Cancer Center